Nagaki et al. found ALKBH5 was correlated with poor prognosis in high expression level of ESCC patients demonstrating ALKBH5 might be a independent prediction factor of the survival ration. This evidence concerns the gene ALKBH5 and esophageal squamous cell carcinoma.